200 related articles for article (PubMed ID: 36445128)
1. Increased Expression of Efflux Pump
Yu XH; Hao ZH; Liu PL; Liu MM; Zhao LL; Zhao X
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0059422. PubMed ID: 36445128
[TBL] [Abstract][Full Text] [Related]
2. Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA.
López Y; Tato M; Gargallo-Viola D; Cantón R; Vila J; Zsolt I
Int J Antimicrob Agents; 2020 Sep; 56(3):106082. PubMed ID: 32659467
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus Efflux Pumps and Tolerance to Ciprofloxacin and Chlorhexidine following Induction by Mupirocin.
Truong-Bolduc QC; Wang Y; Reedy JL; Vyas JM; Hooper DC
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0184521. PubMed ID: 34930023
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
5. Systematic Analysis of Efflux Pump-Mediated Antiseptic Resistance in Staphylococcus aureus Suggests a Need for Greater Antiseptic Stewardship.
LaBreck PT; Bochi-Layec AC; Stanbro J; Dabbah-Krancher G; Simons MP; Merrell DS
mSphere; 2020 Jan; 5(1):. PubMed ID: 31941819
[No Abstract] [Full Text] [Related]
6. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
Martin ALAR; Pereira RLS; Rocha JE; Farias PAM; Freitas TS; Caldas FRL; Figueredo FG; Sampaio NFL; Oliveira-Tintino CDM; Tintino SR; da Hora GCA; Lima MCP; de Menezes IRA; Carvalho DT; Coutinho HDM; Fonteles MMF
Microb Pathog; 2024 May; 190():106608. PubMed ID: 38503396
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of expression of NorA efflux pump in ciprofloxacin resistant Staphylococcus aureus against hexahydroquinoline derivative by real-time PCR.
Pourmand MR; Yousefi M; Salami SA; Amini M
Acta Med Iran; 2014; 52(6):424-9. PubMed ID: 25130148
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the Molecular Recognition Mechanism of Multidrug Resistance
Palazzotti D; Bissaro M; Bolcato G; Astolfi A; Felicetti T; Sabatini S; Sturlese M; Cecchetti V; Barreca ML; Moro S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430864
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
[TBL] [Abstract][Full Text] [Related]
11. Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes.
Huet AA; Raygada JL; Mendiratta K; Seo SM; Kaatz GW
Microbiology (Reading); 2008 Oct; 154(Pt 10):3144-3153. PubMed ID: 18832320
[TBL] [Abstract][Full Text] [Related]
12. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of Mimosa caesalpiniifolia Benth and its interaction with antibiotics against Staphylococcus aureus strains overexpressing efflux pump genes.
Silva SWC; Monção NBN; Araújo BQ; Arcanjo DDR; Ferreira JHL; Lima Neto JS; Citó AMGL; de Siqueira Júnior JP; Kaatz GW; Barreto HM
Lett Appl Microbiol; 2019 Jul; 69(1):57-63. PubMed ID: 31002429
[TBL] [Abstract][Full Text] [Related]
14. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
[TBL] [Abstract][Full Text] [Related]
15. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
Naaz F; Khan A; Kumari A; Ali I; Ahmad F; Ahmad Lone B; Ahmad N; Ali Khan I; Rajput VS; Grover A; Shafi S
Bioorg Chem; 2021 Aug; 113():105031. PubMed ID: 34089943
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Gene Expression of
Saad Latteef N; Salih WY; Aziz Abdulhassan A; Jasim Obeed R
Arch Razi Inst; 2022 Oct; 77(5):1987-1993. PubMed ID: 37123124
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus.
Truong-Bolduc QC; Ding Y; Hooper DC
J Bacteriol; 2008 Nov; 190(22):7375-81. PubMed ID: 18805983
[TBL] [Abstract][Full Text] [Related]
18. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
[TBL] [Abstract][Full Text] [Related]
19. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.
Muñoz-Bellido JL; Alonzo Manzanares M; Martínez Andrés JA; Guttiérrez Zufiaurre MN; Ortiz G; Segovia Hernández M; García-Rodríguez JA
Antimicrob Agents Chemother; 1999 Feb; 43(2):354-6. PubMed ID: 9925531
[TBL] [Abstract][Full Text] [Related]
20. New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains.
Felicetti T; Cedraro N; Astolfi A; Cernicchi G; Mangiaterra G; Vaiasicca S; Massari S; Manfroni G; Barreca ML; Tabarrini O; Biavasco F; Cecchetti V; Vignaroli C; Sabatini S
Eur J Med Chem; 2022 Nov; 241():114656. PubMed ID: 35963131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
